Professional Documents
Culture Documents
2014 - Pulmonary Hypertension and Right Ventricular Dysfunction in Hemodialysis Patients PDF
2014 - Pulmonary Hypertension and Right Ventricular Dysfunction in Hemodialysis Patients PDF
tion consisted of 70 ESRD patients (males/females: (LA), diameter of left ventricular (LV), diameter of
42/28, age 54.9 12.9 years) who were maintained right atria (RA), diameter of RV, thickness of inter-
on long-term hemodialysis therapy via surgically ventricular septum (IVS) and thickness of left ven-
created native arteriovenous access. Patients 18 tricular posterior wall (LVPW)13. Ejection fraction
years who had been on maintenance therapy for at of the left ventricular was calculated using the
least 3 months and were receiving hemodialysis modified Simpson method in the 4-chamber view.
sessions 3 times per week, were enrolled. Each ses- The tricuspid systolic jet (TR) was measured by
sions lasted for 4h and used bicarbonate-buffered from the 4-chamber view with the continues-wave
dialysate. All of these patients were used radial arte- Doppler probe. In the presence of tricuspid valve
riovenous fistula. 48 patients were exclude due to regurgitation, systolic pulmonary artery pressure
comorbid conditions with a high probability of sec- was calculated using the simplified Bernoulli equa-
ondary pulmonary hypertension (sever valvular tion: sPAP = 4*(TR)2 + right artrial pressure. Right
heart disease [n = 11], congenital left-right shunts atrium pressure was estimated from inferior vena
[n = 3], a history of coronary artery stent installa- cava (IVC) and its collapsibility. Pulmonary hyper-
tion [n=5 ], connective tissue disorders [n = 4], pul- tension is defined as an increased of mean pul-
monary thromboembolic disease [n = 5], chronic monary artery pressure above 25 mmHg at rest in
cor pulmonale [n = 7], chronic obstructive pul- the setting of normal or reduced cardiac output and
monary disease [n = 13]). 5 patients had renal trans- normal pulmonary capillary pressure.However, ac-
plantation and 3 patients had atrial fibrillation were cording to the echocardiographic criteria, pul-
also not enrolled. All patients signed an informed monary hypertension is defined as sPAP > 35
consent before entering the study. Our study has mmHg at rest14.
been approved by West China Hospital Ethics Early (E) and late (A) right ventricular inflow
Committee. velocities were measured with pulse-wave
Doppler by placing the sample volume in between
Clinical and Laboratory Investigations the tips of the tricuspid valve in the apical 4-cham-
Each patients general data (age, sex, systolic ber window. S (systolic myocardial velocity), E
blood pressure, diastolic blood pressure, medica- (protodiastolic myocardial velocity) and A (late
tion used, etiology of renal disease) and data re- peak diastolic myocardial velocity) of the right
garding the hemodialysis (dialytic age, interdialyt- ventricular were recorded by tissue Doppler imag-
ic weight gain, Kt/V values) were recorded. Kt/V ing (TDI). The deceleration time (DT-E), ejection
values were calculated by Daugirdas second gen- time (ET), isovolumic relaxation time (IVRT) and
eration equation: Kt/Vsp = -In(R-0.08t) + [(4- isovolumic contraction (IVCT) were also mea-
3.5R) UF/W], where t was the session length sured. Calculation of right ventricular myocardial
in hours and R was the ratio of postdialysis to the performance index (MPI) by tissue Doppler imag-
predialysis plasma urea nitrogen concentrations. ing is defined as the ratio of isovolumic time di-
UF is short for ultrafiltrate volume in liters. W is vided by (IVRT + IVCT)/ET. TDI of MPI value is
the postdiamysis weight in kilograms12. Laborato- reproducible and relatively independent of pre-
ry investigations (hemoglobin, hematocrit, albu- load. The upper reference limit for the right-sided
min, serum calcium, phosphorus, parathyroid hor- TDI of MPI value is 0.5515. Tricuspid annular
mone) were also determined. All the laboratory plane systolic excursion (TAPSE), indices of right
data were done in the same week when the patient ventricular systolic function, was acquired by
underwent Doppler echocardiography. placing an M-mode cursor through tricuspid annu-
lus. TAPSE is a method to measure the amount of
Echocardiography longitudinal motion of the RV annular segment at
All enrolled patients underwent Doppler peak systole. It is inferred that the greater the de-
echocardiography within 1-2 hours after comple- scent of the base in systole is associated with bet-
tion of the hemodialysis to avoid volume overload ter RV systolic function14. The four chambers were
which may lead to overestimated of sPAP. Each pa- measured through apical 4-chamber view at the
tient were examined by an experienced echocardio- same time. RV wall thickness was measured at
graphist. All echocardiography parameters were end-diastole by M-mode from the subcostal win-
measured by a Philips (Eindhoven, The Nether- dow, at the level of the tip of the anterior tricuspid
lands) iE-33 ultrasound machine. The following leaflet or left parasternal windows. Right ventricu-
measurements were taken on two-Dimensional and lar hypertrophy was defined as RV wall thickness
M-mode echocardiography: diameter of left atria 5 mm16.
3268
Pulmonary hypertension and right ventricular dysfunction in hemodialysis patients
The vascular access was acquired soon after in < 0.05 to remain in the final model. All analyses
the longitudinal and transverse planes from the ar- were conducted using standard statistical software
terial anastomosis through the entire access by (IBM, SPSS 20.0 New York, NY, USA). All p val-
means of ultrasonic Doppler (Philips iE-33 ultra- ues < 0.05 were considered to be statistically sig-
sound machine). Vascular blood flow was calculat- nificant.
ed by multiplying the time-averaged velocity
(TAV) by the cross-sectional area of the access17.
The calculations of vascular blood flow is Qa = Results
TAVr260. Here, r is the radius of the arterial
anastomosis. Baseline Characteristics
Data from the 27 patients with pulmonary hyper-
Statistical Analysis tension were compared with those of the 43 patients
Values are expressed as means standard devi- without pulmonary hypertension (Table I). Groups
ation and as a percentage for categorical parame- did not show significant differences regarding the
ters. Clinical variables were compared between age, gender, body mass index (BMI), heart rates
patients with and without pulmonary hyperten- and diastolic blood pressure. However, the systolic
sion. Differences between continuous variables of blood pressure was significant higher in pulmonary
the two subgroups were compared with Students hypertension patients as compared with those with-
t-test and Mann-Witney-U test, as applicable. Chi- out pulmonary hypertension (Table I). The common
square test was used to evaluate the categorical pa- etiologies of renal failure were hypertension, dia-
rameters between the groups. Two-tailed bivariate betes mellitus, glomerulonephritis. The incidence of
correlations were estimated by the Pearsons coef- antihypertensive medications were distributed in
ficient. Multivariate regression analysis was per- similar proportions (Table I). The mean duration of
formed to determine the relationship between pul- dialysis as well as the interdialytic weight gain in
monary hypertension and other covariates (demo- patients demonstrated no significant differences be-
graphic, clinical or hemodynamic). Those convari- tween the two subgroups.Interestingly, the Kt/V
ates were required to have a p-value of < 0.2 to en- values was lower in patients with pulmonary hyper-
ter the stepwise forward selection and a p-value of tension (Table I).
Footnote: ARBs, angiotensin receptor blockers; CCB, calcium channel blockers. 1 mmHg = 0.1333 kPa.
3269
L.-J. Zhao, S.-M. Huang, T. Liang, H. Tang
3270
Pulmonary hypertension and right ventricular dysfunction in hemodialysis patients
vealed to developed to RVH in patients with pul- reported in the previous studies18,19. The mecha-
monary hypertension. While only 9.30% patients nisms of pulmonary hypertension mainly derived
without pulmonary hypertension resulted in RVH. from elevated pulmonary blood flow and increased
Compared with the patients without pulmonary pulmonary vascular resistance. Pulmoanry artery
hypertension, patients with pulmonary hyperten- pressure may be increased by high cardiac output
sion showed a prolonged IVRT but lower TAPSE due to the arteriovenous access, further worsened
(Table III). MPI values, echocardiography para- by fluid overload in hemodialysis patients. Pres-
meters of right ventricular systolic and diastolic sure-induced mediator regulation may represent an
function,was significantly higher in patients with early event in the development of secondary pul-
pulmonary hypertension (p = 0.033 and p = 0.010 monary hypertension in chronic renal failure pa-
respectively) (Table III). It indicated that right tients. Prolonged hypertension may effect pul-
ventricular function was impaired in patients with monary circulation. A recent research confirmed
pulmonary hypertension than those without pul- that endothelial dysfunction were associated with
monary hypertension. increased vasoconstrictors like ehdothelin-1 and
decreased vasodilators such as NO20. Worsen,
Indices of Vascular Access chronic renal failure patients displayed metabolic
Vascular access parameters including the di- and hormonal derangements which may result in
ameter of the arteriovenous fistula and the vascu- pulmonary arterial vasoconstriction.
lar access flow (Qb) were measured by ultrasonic A positive relationship between the sPAP and
Doppler at the same time. Patients with pul- RV wall thickness was revealed. To adopting to
monary hypertension had higher Qb compared the high pressure of pulmonary circulation, end
with patients with normal sPAP (1004.25 sysytolic pressure of right ventricle increased.
179.83 ml/min vs. 996.80 220.03 ml/min). Chronic right ventricular pressure overload leads
However, the difference was no statistically sig- to functional tricuspid valve insufficiency, initiat-
nificant (p = 0.887). ing pathological RV remodeling and results in
compensatory RVH to decrease wall stress, which
Risk of Pulmonary Hypertension ultimately leading to right heart failure. It has at-
in Hemodialysis Patients tributed direct ventricular interaction to the sep-
A significantly positive correlation was noted be- tum, via the trans-septal pressure gradient21. This
tween sPAP and those three parameters as RV wall pathological physiology change was confirmed by
thickness (r = 0.460, p < 0.001), MPI values (r = the negative correlation between LVEF and RV
0283, p = 0.019) and systolic blood pressure (r = wall thickness in our study.
0.279, p = 0.020). On the contrary, sPAP inversely Although researches have mainly focused their
correlated with left ventricular ejection fraction attention on left ventricular function in hemodialy-
(LVEF) (r = -0.27, p = 0.025), hemoglobin (r = - sis patients22,23, insight into the role of RV function
0.337, p = 0.005) and Kt/V values (r = -0.330, p = in pulmonary hypertension patients is scarce. TDI
0.006). A further comparison between the two ure- has considered as a strong diagnostic method in
mic subgroups revealed that LVEF was significant- detecting subclinical abnormalities in cardiac
ly lower in patients with pulmonary hypertension function, which had been demonstrated to predict
than those without pulmonary hypertension (Table mortality24,25. Thus, the detection of RVD would
III). Logistic regression analysis adjusted for the be helpful in early detection of higher risk of de-
same confounding factors such as age, gender, BMI veloping right heart failure. Our study revealed
and HR. The multivariate determinants of pul- that nearly half of hemodialysis were associated
monary hypertension were systolic blood pressure with RVD. Interestingly, MPI values was positive-
(regression coefficient b: 0. 050,odds ratio 1.051 ly correlated with sPAP. The potential mechanism
per mmHg, p = 0. 011) and Kt/V values (regression of this clinical feature is chronic volume overload
coefficient b: -1.394, odds ratio 0.248, p = 0. 044). has affect right ventricular function independently
from post-load conditions10. Arteriovenous fistula
induced volume overload lead to increased sPAP
Discussion plays a crucial role in triggering RVD in mainte-
nance hemodialysis patients.
The study confirmed that uremic patients on Although the present study showed no direct
chronic dialysis treatment showed a high preva- relationship between access flow of AVF and
lence of pulmonary hypertension which had been sPAP, which was similar to other clinical trails3-26.
3271
L.-J. Zhao, S.-M. Huang, T. Liang, H. Tang
We avoided the patients with brachial AVFs. The hemodialysis patients in the United States: preva-
blood flow of AVF was confirmed to be higher in lence and clinical significance. Int J Gen Med
upper arm AVFs than lower AVFs27. Although 2010; 3: 279-286.
our study demonstrated a high prevalence of pul- 9) LI Z, LIU S, LIANG X, WANG W, FEI H, HU P, CHEN
Y, XU L, LI R, SHI W. Pulmonary hypertension as an
monary hypertension and RVD among hemodial- independent predictor of cardiovascular mortality
ysis patients, it provoques some criticisms. All and events in hemodialysis patients. Int Urol
the vascular access parameters were measured by Nephrol 2013 Jun 21. [Epub ahead of print].
ultrasonic Doppler in the present study, which 10) PIAZZA G, GOLDHABER SZ.The acutely decompen-
will be less reliably than Transonic Hemodialysis sated right ventricle: pathways for diagnosis and
Monitor HD0228. As peritoneal dialysis patients management. Chest 2005; 128: 1836-1852.
who were reported had pulmonary hypertension 11) GRAPSA J, DAWSON D, NIHOYANNOPOULOS P. Assess-
in the recent research29, data of RVD in those pa- ment of right ventricular structure and function in
pulmonary hypertension. J Cardiovasc Ultrasound
tients are lacking up to now which will be a re- 2011; 19: 115-125.
search topic in the future. 12) DAUGIRDAS JT. Second generation logarithmic esti-
mates of single-pool variable volume Kt/V: an analy-
- sis of error. J Am Soc Nephrol 1993; 4: 1205-1213.
Conflict of Interest 13) L ANG RM, B IERIG M, D EVEREUX RB, F LACHSKAMPF
The Authors declare that there are no conflicts of interest. FA, F OSTER E, P ELLIKKA PA, P ICARD MH, R OMAN
MJ, S EWARD J, S HANEWISE J, S OLOMON S, S PENCER
KT, ST JOHN SUTTON M, STEWART W; Recommenda-
tions for chamber quantification. Eur J Echocar-
References diogr 2006; 7: 79-108.
14) ROSENKRANZ S. Pulmonary hypertension: current di-
1) YAMAGUCHI S, GOHDA T, GOTOH H, OMOTE K, FU- agnosis and treatment. Clin Res Cardiol 2007; 96:
RUKAWA M, ISHIKAWA Y, TOMINO Y. Factors associated 527-541.
with cardiovascular death and events in patients
with end stage renal disease. Nihon Jinzo Gakkai 15) RUDSKI LG, LAI WW, AFILALO J, HUA L, HANDSCHUMACH-
ER MD, C HANDRASEKARAN K, S OLOMON SD, L OUIE
Shi 2013; 55: 159-166.
EK, SCHILLER NB. Guidelines for the Echocardio-
2) NUGENT RA, FATHIMA SF, FEIGL AB, CHYUNG D. The graphic Assessment of the Right Heart in Adults: a
burden of chronic kidney disease on developing report from the American Society of Echocardiogra-
nations: A 21st century challenge in global health. phy. J Am Soc Echocardiogr 2010; 23: 685-713.
Nephron Clin Pract 2011; 118: c269-277.
16) PRAKASH R. Echocardiographic diagnosis of right
3) UNAL A, TASDEMIR K, OYMAK S, DURAN M, KOCYIGIT ventricular hypertrophy: correlation with ECG and
I, OGUZ F, TOKGOZ B, SIPAHIOGLU MH, UTAS C, OYMAK necropsy findings in 248 patients.Cathet Cardio-
O. The long-term effects of arteriovenous fistula vasc Diagn 1981; 7: 1179-1184.
creation on the development of pulmonary hyper-
17) MAGNASCO A, ALLOATTI S, MARTINOLI C, SOLARI P. Glu-
tension in hemodialysis patients. Hemodial Int
cose pump test: a new method for blood flow
2010; 14: 398-402.
measurements. Nephrol Dial Transplant 2002; 17:
4) FABBIAN F, CANTELLI S, MOLINO C, PALA M, LONGHINI 2244-2248.
C, PORTALUPPI F. Pulmonary hypertension in dialysis
18) KOSMADAKIS G, AGUILERA D, CARCELES O, DA COSTA
patients:a cross-sectional italian study. Int J
CORREIA E, BOLETIS I. Pulmonary hypertension in
Nephrol 2010; 30: 1-4.
dialysis patients. Ren Fail 2013; 35: 514-520.
5) AGARWAL R. Prevalence, determinants and progno-
19) OYGAR DD, ZEKICAN G. Pulmonary hypertension in
sis of pulmonary hypertension among hemodialy-
dialysis patients.Ren Fail 2012; 34: 840-844.
sis patients. Nephrol Dial Transplant 2012; 27:
3908-3914. 20) NAKHOUL F, YIGLA M, GILMAN R, REISNER SA, ABASSI Z.
The pathogenesis of pulmonary hypertension in
6) ETEMADI J, ZOLFAGHARI H, FIROOZI R, ARDALAN MR, TO- haemodialysis patients via arteriovenous access.
UFAN M, SHOJA MM, GHABILI K. Unexplained pul-
Nephrol Dial Transplant 2005; 20: 1686-1692.
monary hypertension in peritoneal dialysis and
hemodialysis patients. Rev Port Pneumol 2012; 21) KINGMA I, TYBERG JV, SMITH ER. Effects of diastolic
18: 10-14. transseptal pressure gradient on ventricular sep-
tal position and motion. Circulation 1983; 68:
7) DAGLI CE, SAYARLIOGLU H, DOGAN E, ACAR G, DEMIRPO- 1304-1314.
LAT G, OZER A, KOKSAL N, GELEN ME, ATILLA N, TAN-
RIKULU AC, ISIK IO, UGUR T. Prevalence of and factors 22) GULEL O, SOYLU K, YUKSEL S, KARAOGLANOGLU M, CEN-
affecting pulmonary hypertension in hemodialysis GIZ K, DILEK M, HAMISEYEV C, KALE A, ARIK N. Evi-
patients. Respiration 2009; 78: 411-415. dence of left ventricular systolic and diastolic dys-
function by color tissue Doppler imaging despite
8) RAMASUBBU K, DESWAL A, HERDEJURGEN C, AGUILAR normal ejection fraction in patients on chronic he-
D, F ROST AE. A prospective echocardiographic modialysis program. Echocardiography 2008; 25:
evaluation of pulmonary hypertension in chronic 569-574.
3272
Pulmonary hypertension and right ventricular dysfunction in hemodialysis patients
23) HAYASHI SY, ROHANI M, LINDHOLM B, BRODIN LA, LIND B, S, KARAMAN O, ACAR M. The relationship between ar-
BARANY P, ALVESTRAND A, SEEBERGER A. Left ventricular teriovenous fistula blood flow rate and pulmonary
function in patients with chronic kidney disease artery pressure in hemodialysispatients. Int Urol
evaluated by colour tissue Doppler velocity imag- Nephrol 2008; 40: 509-513.
ing. Nephrol Dial Transplant 2006; 21: 125-132. 27) BASILE C, LOMONTE C, VERNAGLIONE L, CASUCCI F, AN-
24) KITTIPOVANONTH M, BELLAVIA D, CHANDRASEKARAN K, TONELLI M, LOSURDO N. The relationship between
VILLARRAGA HR, ABRAHAM TP, PELLIKKA PA. Doppler the flow of arteriovenous fistula and cardiac out-
myocardial imaging for early detection of right put in haemodialysis patients. Nephrol Dial Trans-
ventricular dysfunction in patients with pulmonary plant 2008; 23: 282-287.
hypertension. J Am Soc Echocardiogr 2008; 21: 28) KRIVITSKI N, SCHNEDITZ D. Arteriovenous vascular ac-
1035-1041. cess flow measurement: accuracy and clinical im-
25) WANG AY, WANG M, LAM CW, CHAN IH, ZHANG Y, SANDER- plications. Contrib Nephrol 2004; 142: 269-284.
SON JE. Left ventricular filling pressure by Doppler 29) U NAL A, S IPAHIOGLU M, O GUZ F, K AYA M, K UCUK
echocardiography in patients with end-stage renal H, TOKGOZ B, BUYUKOGLAN H, OYMAK O, UTAS C. Pul-
disease. Hypertension 2008; 52: 107-114. monary hypertension in peritoneal dialysis pa-
26) ACARTURK G, ALBAYRAK R, MELEK M, YUKSEL S, USLAN tients: prevalence and risk factors. Perit Dial
I, ATLI H, COLBAY M, UNLU M, FIDAN F, ASCI Z, CANDER Int 2009; 29: 191-198.
3273